The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
This is precisely where StockStory comes in - we do the heavy lifting to identify companies with solid fundamentals so you can invest with confidence. Keeping that in mind, here are three stocks under $50 to swipe left on and some alternatives you should look into instead.
Pfizer (PFE)
Share Price: $25.19
With roots dating back to 1849 when two German immigrants opened a fine chemicals business in Brooklyn, Pfizer (NYSE:PFE) is a global biopharmaceutical company that discovers, develops, manufactures, and sells medicines and vaccines for a wide range of diseases and conditions.
Why Do We Think Twice About PFE?
- Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
- Free cash flow margin dropped by 26.6 percentage points over the last five years, implying the company became more capital intensive as competition picked up
- Diminishing returns on capital suggest its earlier profit pools are drying up
Pfizer’s stock price of $25.19 implies a valuation ratio of 8.5x forward P/E. Check out our free in-depth research report to learn more about why PFE doesn’t pass our bar.
P10 (PX)
Share Price: $9.89
Operating as a bridge between institutional investors and hard-to-access private market opportunities, P10 (NYSE:PX) is an alternative asset management firm that provides access to private equity, venture capital, impact investing, and private credit opportunities in the middle and lower middle markets.
Why Does PX Give Us Pause?
- Annual earnings per share growth of 7.1% underperformed its revenue over the last two years, showing its incremental sales were less profitable
- Low return on equity reflects management’s struggle to allocate funds effectively
P10 is trading at $9.89 per share, or 9.4x forward P/E. Dive into our free research report to see why there are better opportunities than PX.
United Bankshares (UBSI)
Share Price: $38.39
With roots dating back to 1982 and a strong presence in the Mid-Atlantic region, United Bankshares (NASDAQ:UBSI) is a bank holding company that provides commercial and retail banking services through its United Bank subsidiary across multiple states.
Why Are We Out on UBSI?
- Muted 4.5% annual revenue growth over the last two years shows its demand lagged behind its banking peers
- Earnings growth underperformed the sector average over the last five years as its EPS grew by just 3.9% annually
- Estimated tangible book value per share growth of 6.2% for the next 12 months implies profitability will slow from its two-year trend
At $38.39 per share, United Bankshares trades at 1x forward P/B. Read our free research report to see why you should think twice about including UBSI in your portfolio.
Stocks We Like More
Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.
The names generating the next wave of massive growth are right here in our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today.